|
Betting
big on CDM
With a strong IT base and a booming clinical research industry
India is proving to be a good destination for Clinical Data
Management (CDM) outsourcing. Arshiya Khan analyses the trends
and the outsourcing models
Lupin
acquires Pharma Dynamics in South Africa
Lupin recently completed acquisition of a majority stake (60
percent) in Pharma Dynamics (PD) in South Africa, expressing
plans to acquire further in future
'We
are the only country providing formal training for clinical
trials'
Professor Christoph Thiemermann, CEO, William Harvey Research
Limited (WHRL), UK, gives an insight into WHRL's collaboration
with CREMA (Clinical Research Education and Management Academy)
and more on international research education trends and education
in India, in conversation with Arshiya Khan
BioImagene
becomes Burrill & Co's first investment in India
BioImagene, a leading provider of affordable digital pathology
solutions for cancer diagnosis and preclinical research, based
out of Cupertino, California and with an IT development centre
in Pune, recently received $26 million in venture financing
from investors led by Burrill & Company, Ascension Health
Ventures, and National Healthcare Services
Xcelris
ties up with DMRI
Xcelris Labs, a Contract Research Organisation (CRO) promoted
by Claris Lifesciences, has entered into a strategic alliance
agreement with Drug Monitoring and Research Institute (DMRI),
Mumbai
Wanbury
to invest Rs 50-60 crore in facility upgradation
Wanbury has plans to invest Rs 50-60 crore for upgrading its
manufacturing facilities in India, which will be funded through
Foreign Currency Convertible Bonds (FCCBs), internal accruals
and term loans
Sun
gets US FDA nod for Fosamax
Sun Pharmaceuticals has obtained final Food and Drug Administration
(FDA) approval for its Abbreviated New Drug Application (ANDA)
generic, alendronate sodium tablets
Aurobindo
gets tentative US FDA approval for AIDS drug
Aurobindo Pharma has received tentative United States Food
and Drug Administration (US FDA) approval for its New Drug
Application (NDA) abacavir sulfate 60mg tablets
AVP
to invest Rs 20 crore
Arya Vaidya Pharmacy (AVP) is expanding its presence in the
domestic market with a total investment of Rs 20 crore
Camlin
to set up manufacturing facility in Maharashtra
Camlin Fine Chemicals is setting up its new manufacturing
unit for producing active pharmaceutical ingredients (APIs)
at Pali, Maharashtra
Dr
Batra's to set up 10 new centres across globe
Dr Batra's Positive Health Clinic (DBPHCPL) is expanding its
presence in domestic as well international markets. For the
current financial year company has plans to invest Rs six
crore for setting up 10 new centres
Event
Brief
Indian
pharma needs to tap emerging opportunities—KPMG study
Indian pharma has made impressive strides in the global arena
across different business segments and has demonstrated its
ability to play a leadership role in each of them
Fourth
Pharmexcil AGM concludes at Hyderabad
Pharmaceuticals Export Promotion Council (Pharmexcil), Hyderabad
recently had its fourth annual general body meeting (AGM)
on 12th September 2008, at Hotel Taj Deccan, Banjara Hills
in Hyderabad
|
